PMHNP Practice Authority in Alaska: Independence, Physician Agreements and Schedule II

AANP's May 2026 map puts Alaska in its full practice tier.

The label is AANP's advocacy classification; the legal facts behind it sit in the Board of Nursing's regulations.

12 AAC 44.430 has the board recognize advanced and specialized acts of nursing practice as described in the scope statements of national professional nursing associations, and 12 AAC 44.440(a) lets the board authorize an APRN to prescribe and dispense legend drugs under applicable state and federal law — with no collaboration, supervision or protocol requirement anywhere in the rules read.

One limit on the claim: the statute, AS 08.68, was not part of the sources read, so no statutory independent-practice sentence can be quoted; what this page establishes is the Board of Nursing's regulations.

Nothing in the rules read requires hours or years of practice before an Alaska APRN prescribes.

The gates are documentary: legend prescriptive authority requires that the applicant be currently designated as an APRN, show 15 contact hours of education in advanced pharmacology and clinical management of drug therapy completed within the two-year period immediately before the date of application, and pay the fee (12 AAC 44.440(b)).

Controlled-substance authority under 12 AAC 44.445(a) is a further form and fee, not a time-in-practice threshold.

A new graduate therefore moves to prescribing on applications alone, and a clinician relocating to Alaska finds nothing in these rules that defers prescriptive authority behind years of supervised service.

The read of the five APRN regulations (12 AAC 44.430, 44.440, 44.445, 44.447 and 44.925) found no prescriptive authority agreement, no physician ratio, no meeting frequency, no chart-review percentage and nothing filed with a medical board.

The control that takes a physician agreement's place is the board's own disciplinary authority: 12 AAC 44.440(d) lets the board limit, restrict, deny, suspend or revoke prescriptive authorization or APRN licensure on grounds that include letting licensure or national certification lapse, prescribing in an unsafe manner or without adequate instruction to patients, and prescribing to people who are not the APRN's patients or outside the nurse's role and population foci.

On a separate application the board may authorize an APRN to prescribe and dispense schedule II-V controlled substances (12 AAC 44.445(a)).

No day-supply or drug-class limit on Schedule II stimulants appears in the APRN rules, so an outpatient Alaska PMHNP can prescribe them with that authorization and a DEA registration in hand.

The one dosage limit in the APRN rules is opioid-specific: 44.445(j) states a maximum daily dosage of 50 MME for a patient's initial opioid prescription — a class cap reaching Schedule II opioids but not stimulants.

44.445(i) has DEA-number applicants verify two hours of pain management and opioid use and addiction education within the two years before applying.

PDMP duties attach: registration with the controlled substance prescription database (44.445(d)) and a check before a federal Schedule II or III drug is first dispensed, prescribed or administered, repeated at least once every 30 days for up to 90 days and at least once every three months beyond that, with exceptions including hospice care and a non-refillable three-day supply with no further prescription for the next 15 days (44.445(g)).

Alaska's prescriptive authority includes dispensing: an APRN may dispense within scope, must dispense prepackaged medication in its original package, and is responsible for labeling, delivery and patient counseling under 12 AAC 44.447.

Telehealth has its own standards rule, 12 AAC 44.925: diagnosis, treatment or prescribing without a physical examination requires the same standard of care as in person, documented informed consent, a clinical history, a plan of care, patient and provider locations, the provider-patient relationship before prescribing, a provider available for follow-up care, and HIPAA-compliant, secure transmissions.

Federally, the PMHNP registers with the DEA as a mid-level practitioner (21 CFR 1300.01) — a registration that covers only what Alaska allows — and the DEA/HHS telemedicine flexibilities, extended through December 31, 2026 (90 FR 61301), remove the federal in-person requirement without altering these board standards.

Alaska has not enacted the APRN Compact.

The compact takes effect only once seven states enact it, and as of September 2026 five had (Delaware, North Dakota, South Dakota, Utah and Wyoming), so no APRN holds a multistate APRN licence today.

The Nurse Licensure Compact is an RN compact and gives no nurse practitioner authority in another state.

To practise as a PMHNP in Alaska you need the Alaska APRN designation — the rules' own word — from the Board of Nursing.

The most recent amendment in the sources read is to 12 AAC 44.925, the telehealth standards, amended effective 2024-01-05 (Register 249, April 2024); that rule adopts the American Association of Nurse Practitioners' 2022 telehealth position statement by reference.

12 AAC 44.440 was last amended 2022-01-19.

The underlying statute, AS 08.68, was not read, so statutory amendments from 2023 to 2026 cannot be ruled out from this page's sources — confirm current text with the Board of Nursing before relying on it.